Most sold healthcare stocks in Q3 2024

See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2024, measured as net reductions in reported share positions from Q2 2024 into Q3 2024. Notable reductions at the top of this list include TELADOC HEALTH INC (TDOC), STANDARD BIOTOOLS INC (LAB), PFIZER INC (PFE), CAREDX INC (CDNA). These rankings are based on SEC 13F filings from the investors we track.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
TDOCTELADOC HEALTH INC-8,039,762-$81.58M00111
LABSTANDARD BIOTOOLS INC-4,533,184$2.82M00203
PFEPFIZER INC-4,269,901-$100.96M067114
CDNACAREDX INC-3,364,792$23.38M00303
GEHCGE HEALTHCARE TECHNOLOGY-3,290,887$112.17M01517
ABTABBOTT LABORATORIES-3,016,601-$102.42M123110
SGRYSURGERY PARTNERS INC-2,941,523-$67.87M00111
FDMT4D MOLECULAR THERAPEUTICS IN-2,934,914-$61.60M00010
VERVVERVE THERAPEUTICS INC-2,835,777-$13.86M01011
JNJJOHNSON & JOHNSON-1,738,729-$156.85M065115
VCYTVERACYTE INC-1,715,052$31.06M01102
LFSTLIFESTANCE HEALTH GROUP INC-1,713,677$14.23M10203
NVONOVO-NORDISK A/S-SPONS ADR-1,569,683-$611.27M00406
FTREFORTREA HOLDINGS INC-1,509,775-$15.53M00212
GILDGILEAD SCIENCES INC-1,363,447$499.20M00808
CERSCERUS CORP-1,326,153-$2.71M01102
MPLNMULTIPLAN CORP-1,216,000-$472.29K00010
ME23ANDME HOLDING CO -CLASS A-1,137,918-$580.14K00101
ALLOALLOGENE THERAPEUTICS INC-1,105,946-$2.28M00101
UNHUNITEDHEALTH GROUP INC-1,099,869$657.70M11013326
SNYSANOFI-ADR-1,099,428$649.47M02214
BEAMBEAM THERAPEUTICS INC-1,095,040-$18.67M00101
HLNHALEON PLC-ADR-1,093,446$414.75M02406
IRWDIRONWOOD PHARMACEUTICALS INC-1,078,925-$27.67M01011
INSMINSMED INC-1,035,970-$69.41M00010
MRSNMERSANA THERAPEUTICS INC-955,500-$1.98M00101
WBAWALGREENS BOOTS ALLIANCE INC-920,446-$14.71M11103
VXRTVAXART INC-919,631-$609.13K00111
SRDXSURMODICS INC-912,602-$39.29M00212
AUTLAUTOLUS THERAPEUTICS PLC-894,185-$3.07M00101
CRBUCARIBOU BIOSCIENCES INC-888,700-$1.27M00101
DXCMDEXCOM INC-785,061-$128.31M02113
GERNGERON CORP-781,723-$3.31M00010
CARACARA THERAPEUTICS INC-779,494-$90.01K01102
STIMNEURONETICS INC-779,409-$2.01M01011
AAGILENT TECHNOLOGIES INC-751,688$12.24M01305
BCABBIOATLA INC-748,059-$825.39K00111
TMOTHERMO FISHER SCIENTIFIC INC-638,076$25.52M119011
CAHCARDINAL HEALTH INC-634,534-$32.89M03116
MCKMCKESSON CORP-615,282-$377.34M11125
VKTXVIKING THERAPEUTICS INC-607,824-$22.89M01102
HUMAHUMACYTE INC-600,300-$2.88M00010
MASS908 DEVICES INC-591,182-$9.00M01102
CHECHEMED CORP-564,250-$303.36M00111
BFLYBUTTERFLY NETWORK INC-559,995$9.53M01102
TWSTTWIST BIOSCIENCE CORP-556,972-$50.29M10102
EXASEXACT SCIENCES CORP-549,602-$14.32M11204
AMLXAMYLYX PHARMACEUTICALS INC-539,688-$661.20K00101
QSIQUANTUM-SI INC-525,764-$2.55M10102
ZTSZOETIS INC-522,130$138.30M045010
20 symbols with net change in reported shares from tracked managers.−8.8M−6.6M−4.4M−2.2M0.00Net change in reported shares (tracked managers)TDOCLABPFECDNAGEHCABTSGRYFDMTVERVJNJVCYTLFSTNVOFTREGILDCERSMPLNMEALLOUNHSymbol

Frequently asked questions about Most sold healthcare stocks in Q3 2024

  • What are the most sold Healthcare stocks in Q3 2024?

    The most sold healthcare stocks in Q3 2024 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q2 2024, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2024?

    Among the managers we track, net reductions were largest in companies such as TELADOC HEALTH INC (TDOC), STANDARD BIOTOOLS INC (LAB), PFIZER INC (PFE), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q2 2024).

  • Does this include all institutional owners?

    These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.